Evidence map›Paper›PMID 30693686›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2018

[Efficacy of brain-targeted rapamycin for treatment of epilepsy in rats].

Yuanyuan Zhang, Qingmei Wang, Jingyin Dong, Binbin Zhang, Luna Liu, Feng Zhu, Linghui Zeng

Open access · greenAbstract read
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuanyuan ZhangSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Qingmei WangSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Jingyin DongSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Binbin ZhangSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Luna LiuSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Feng ZhuSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Linghui ZengSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the efficacy of brain-targeted rapamycin (T-Rap) in treatment of epilepsy in rats.

methodsRapamycin nanoparticles targeting brain were prepared. The epilepsy model was induced by injection of pilocarpine in rats. The rats with pilocarpine-induced epilepsy were treated with rapamycin (Rap group) or brain-targeted rapamycin (T-Rap group). Seizure activity was observed by electroencephalography; the effect on mTOR signaling pathway was detected by Western blot; neuronal death and moss fiber sprouting were analyzed by Fluoro-Jade B (FJB) and Timm's staining, respectively.

resultsElectroencephalography showed that both preparation of rapamycin significantly reduced the frequency of spontaneous seizures in rats, and the effect of T-Rap was stronger than that of conventional rapamycin (

conclusionsT-Rap has a better therapeutic effect on epilepsy than conventional rapamycin with a less adverse effects in rats.

Indexed as

EpilepsySirolimusAnimalsBrainDisease Models, AnimalNeuronsPilocarpineRatsRats, Sprague-DawleySignal TransductionTreatment OutcomePilocarpineSirolimus

Identifiers

PMID30693686
PMCPMC10393660
OpenAlexW2989713622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.